No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
复制标题
与基于干扰素的治疗相比，直接作用抗病毒药物根除丙型肝炎病毒后，肝细胞癌的风险没有增加
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Ikeda F.,et al
中科院分区：
文献类型：
--
作者：
Korenaga M.;Murata K.;Izumi N;Tamaki N.;Yokosuka O.;Takehara T.;Sakamoto N.;Suda G.;Nishiguchi S.;Enomoto H.;Ikeda F.,et al
